Search research articles
Contact Us
Filters
Showing results (31-40 of 33) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 33 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2016
Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study
G A McArthur, M Maio, A Arance, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 5, 2019
Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001
O Hamid, C Robert, A Daud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 28, 2015
A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma
E M Hersh, M Del Vecchio, M P Brown, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 33) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 33 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2016
Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study
G A McArthur, M Maio, A Arance, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 5, 2019
Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001
O Hamid, C Robert, A Daud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 28, 2015
A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma
E M Hersh, M Del Vecchio, M P Brown, et al.
Page
of 4